Exploring the anti-inflammatory effects of postbiotic proteins from Lactobacillus delbrueckii CIDCA 133 on inflammatory bowel disease model
Authors:
- 27 July 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 277 (Pt 2) , 134216
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Protective effect of feruloylated oligosaccharides on dextran sulfate sodium‐induced ulcerative colitis in ratsFood Frontiers, 2022
- MiRNA-182-5p aggravates experimental ulcerative colitis via sponging Claudin-2Journal of Molecular Histology, 2021
- Interleukin‐17—A multifaceted cytokine in viral infectionsJournal of Cellular Physiology, 2021
- Lactobacillus stress protein GroEL prevents colonic inflammationJournal of Gastroenterology, 2021
- TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiotaJournal of Gastroenterology, 2017
- Lactobacillus delbrueckii subsp. lactis (strain CIDCA 133) stimulates murine macrophages infected with Citrobacter rodentiumWorld Journal of Microbiology and Biotechnology, 2017
- Claudin-2 Regulates Colorectal Inflammation via Myosin Light Chain Kinase-Dependent SignalingDigestive Diseases and Sciences, 2013
- Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram‐positive bacteriaProteomics, 2008
- An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene ExpressionMethods, 2001
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001